News

The MitraClip system is reported to be the first commercially available treatment option for non-surgical mitral valve repair for patients suffering from the effects of functional and degenerative

As part of the agreement, University of Pittsburgh Medical Center (UPMC) will extend the Sunquest system, already in 15 of its 20 hospitals, to additional sites. Additionally, after

One of the conditions to Uluru making any offer is that the outstanding debt of York shall be converted into ordinary shares of York prior to the closing

InSite Vision, a developer of new ocular pharmaceutical products, has reported that the Therapeutic Products Directorate of Health Canada has approved the company’s new drug submission for AzaSite

This molecular diagnostic tool helps to identify individuals at elevated risk for early heart attack. As part of the agreement, the test will be marketed by Labec Pharma

The FDA has stated that AstraZeneca did not provide adequate data to establish the appropriate dose or doses of the individual components of Symbicort – budesonide and formoterol

Through this partnership, BioDuro will provide research services in the areas of discovery chemistry and biology, which can help to shorten drug discovery timelines. This agreement is an

The agreement includes joint work in support of potential remedies and to identify effective ways to provide information and education to medical professionals and patients globally. The University

The Altropane Phase III program, called Poet-2, is designed to confirm the diagnostic utility of Altropane in anticipation of drug registration, and includes two, parallel clinical studies enrolling